Clinical Study on the Safety and Efficacy of CD7 CAR-T Cell Sequential Allo-HSCT and Kidney Transplantation in the Treatment of SIOD

EARLY_PHASE1RecruitingINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 30, 2025

Primary Completion Date

January 30, 2028

Study Completion Date

January 30, 2028

Conditions

Schimke Immuno-osseous Dysplasia

Interventions

BIOLOGICAL

CD7 CAR-T cells injection

Intravenous infusion, single dose

PROCEDURE

Allo-HSCT

allogeneic hematopoietic stem cell transplantation

PROCEDURE

Kidney Transplantation

Trial Locations (1)

RECRUITING

The first affiliated hospital of medical college of zhejiang university, Hangzhou

All Listed Sponsors

collaborator

Yake Biotechnology Ltd.

INDUSTRY

lead

Zhejiang University

OTHER